| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
REVIEW ARTICLE |
1 From the Department of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands (GJAW), and the Institute of Human Nutrition, School of Medicine, University of Southampton, Southampton, United Kingdom (PCC)
Total parenteral nutrition is the final option for nutritional support of patients with severe intestinal failure. Lipid emulsions constitute the main source of fuel calories and fatty acids (FAs) in parenteral nutrition formulations. However, adverse effects on patient outcomes have been attributed to the use of lipids, mostly in relation to impaired immune defenses and altered inflammatory responses. Over the years, this issue has remained in the limelight, also because technical advances have provided no safeguard against the most daunting problems, ie, infectious complications. Nevertheless, numerous investigations have failed to produce a clear picture of the immunologic characteristics of the most commonly used soybean oil–derived lipid emulsions, although their high content of n–6 polyunsaturated FAs (PUFAs) has been considered a drawback because of their proinflammatory potential. This concern initiated the development of emulsions in which part of the n–6 FA component is replaced by less bioactive FAs, such as coconut oil (rich in medium-chain saturated FAs) or olive oil (rich in the n–9 monounsaturated FA oleic acid). Another approach has been to use fish oil (rich in n–3 PUFA), the FAs of which have biological activities different from those of n–6 PUFAs. Recent studies on the modulation of host defenses and inflammation by fish-oil emulsions have yielded consistent data, which indicate that these emulsions may provide a tool to beneficially alter the course of immune-mediated conditions. Although most of these lipids have not yet become available on the US market, this review synthesizes available information on immunologic characteristics of the different lipids that currently can be applied via parenteral nutrition support.
Key Words: Total parenteral nutrition • lipid emulsion • immunology • inflammation • fatty acids • eicosanoids
This article has been cited by other articles:
|
|
 |
|
  S. J. Brull Lipid Emulsion for the Treatment of Local Anesthetic Toxicity: Patient Safety Implications Anesth. Analg., May 1, 2008; 106(5): 1337 - 1339. [Full Text] [PDF]
|
|
|
|
 |
|
 M. W Versleijen, W. J Oyen, H. M Roelofs, S. E van Emst-de Vries, P. H Willems, J. B Jansen, and G. J Wanten Immune function and leukocyte sequestration under the influence of parenteral lipid emulsions in healthy humans: a placebo-controlled crossover study Am. J. Clinical Nutrition, March 1, 2008; 87(3): 539 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Gura, S. Lee, C. Valim, J. Zhou, S. Kim, B. P. Modi, D. A. Arsenault, R. A. M. Strijbosch, S. Lopes, C. Duggan, et al. Safety and Efficacy of a Fish-Oil-Based Fat Emulsion in the Treatment of Parenteral Nutrition-Associated Liver Disease Pediatrics, March 1, 2008; 121(3): e678 - e686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hise, C. Compher, and J. Brown Inflammatory Mediators and Home Parenteral Nutrition Nutr Clin Pract, February 1, 2008; 23(1): 42 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. O. Clarke and G. E. Mullin A Review of Complementary and Alternative Approaches to Immunomodulation Nutr Clin Pract, February 1, 2008; 23(1): 49 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Cury-Boaventura, R. Gorjao, T. M. de Lima, J. Fiamoncini, R. P. Torres, J. Mancini-Filho, F. G. Soriano, and R. Curi Effect of Olive Oil-Based Emulsion on Human Lymphocyte and Neutrophil Death JPEN J Parenter Enteral Nutr, January 1, 2008; 32(1): 81 - 87. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
